arrow
G

Guillermo E. Umpierrez

Emory University School of Medicine
H指数:108
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An international position statement on practical approaches for inpatient continuous glucose monitoring, insulin pumps and automated insulin delivery systems in adults

关于成人住院患者连续血糖监测、胰岛素泵和自动化胰岛素输注系统实用方法的国际立场声明

2026-09-220
OAAI
Association of GLP-1 receptor agonists, SGLT 2 inhibitors, DPP-4 inhibitors, and sulfonylureas with incident cancer in type 2 diabetes

GLP-1受体激动剂、SGLT 2抑制剂、DPP-4抑制剂和磺脲类药物与2型糖尿病患者新发癌症的关联

2026-08-170
OAAI
The Impact of Kidney Function on Diabetic Ketoacidosis and Severe Hypoglycemia Among Adults With Type 1 Diabetes: Insights From the T1D Exchange Real-World Observation Study

肾功能对1型糖尿病成人患者糖尿病酮症酸中毒和严重低血糖的影响:来自T1D Exchange真实世界观察研究的研究启示

2026-08-110
PRE
Cardiovascular Effects of Alogliptin, Linagliptin, Saxagliptin, and Sitagliptin: A Target Trial Emulation of a Comparative Effectiveness Study

阿格列汀、利格列汀、沙格列汀和西格列汀的心血管效应:一项比较疗效研究的靶试验模拟研究

2026-04-080
PRE
Research Code Sharing in Support of Gold Standard Science

支持黄金标准科学的代码共享研究

2026-01-140
PRE
Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial

GLP-1受体激动剂在具有中度心血管风险的2型糖尿病成人中对心血管结局的相对有效性:目标试验的模拟研究

2025-09-200
OAAI
Comparative Risk of Adverse Pancreatic Events with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas among Adults with Type 2 Diabetes at Moderate Cardiovascular Disease Risk

GLP-1受体激动剂、SGLT2抑制剂、DPP4抑制剂和磺脲类药物在具有中度心血管疾病风险的2型糖尿病成人中不良胰腺事件的比较风险

2025-09-110
PRE
Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes

2型糖尿病使用钠-葡萄糖共转运蛋白-2抑制剂(SGLT2i)患者的糖尿病相关酮症酸中毒(DKA)的临床特征与结局

2025-09-080
OAAI
CGM Data Analysis 2.0: Functional Data Pattern Recognition and Artificial Intelligence Applications

CGM Data Analysis 2.0:功能数据模式识别和人工智能应用

2025-08-140
OA
Risk of Sight-Threatening Diabetic Retinopathy With GLP-1 RA Use in Routine Clinical Practice: Comparative Effectiveness of Semaglutide, Dulaglutide, Liraglutide, and Exenatide

使用GLP-1 RA治疗在常规临床实践中导致视力威胁性糖尿病视网膜病变的风险:司美格鲁肽、度拉糖肽、利拉鲁肽和艾塞那肽的疗效比较

2025-08-060
PRE